CHM 0.00% 2.1¢ chimeric therapeutics limited

CDH17 trial for gastric, colorectal and NED cancers using best...

  1. 45 Posts.
    lightbulb Created with Sketch. 27
    CDH17 trial for gastric, colorectal and NED cancers using best in class 3rd generation CART is about to kick off. Any one want to guess when Chimeric will announce the first patient dosed for Phase 1?
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
2.1¢
Change
0.000(0.00%)
Mkt cap ! $18.39M
Open High Low Value Volume
2.1¢ 2.1¢ 2.1¢ $5.446K 259.3K

Buyers (Bids)

No. Vol. Price($)
1 2129 2.1¢
 

Sellers (Offers)

Price($) Vol. No.
2.2¢ 737340 7
View Market Depth
Last trade - 15.04pm 30/07/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.